Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., specializes in the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with a significant portion of its revenue coming from overseas due to the depreciation of the RMB [3][4]. Company Overview - Shantou Ultrasonic Instrument Research Institute Co., Ltd. was established on November 15, 1982, and went public on January 22, 2025. It is recognized as a national key high-tech enterprise [7]. - The company's main business segments include medical ultrasound (71.16% of revenue), industrial ultrasound (17.30%), accessories (5.72%), X-ray (4.56%), and other (1.26%) [7]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 254 million yuan, a year-on-year decrease of 2.90%, and a net profit attributable to shareholders of 88.94 million yuan, down 3.66% year-on-year [8][9]. - As of September 30, 2025, the company's overseas revenue accounted for 55.26% of total revenue, benefiting from the depreciation of the RMB [3]. Market Activity - On December 12, the company's stock price increased by 1.09%, with a trading volume of 22.8866 million yuan and a turnover rate of 1.76%, bringing the total market capitalization to 9.552 billion yuan [1]. - The stock has experienced a net outflow of 1.2743 million yuan from major investors today, indicating a lack of strong control by major shareholders, with a very dispersed distribution of shares [5][6]. Recent Developments - The company participated in the 97th WVC Annual Meeting from March 3 to 5, 2025, showcasing its innovative veterinary medical imaging achievements and engaging with industry experts [2].
超研股份涨1.09%，成交额2288.66万元，近3日主力净流入-302.48万